Faculty Bibliography

The pathological cascade of tissue damage in mild traumatic brain injury is set forth by a perturbation in ionic homeostasis. However, whether this class of injury can be detected in vivo and serve as a surrogate marker of clinical outcome is unknown. We employ sodium MRI to test the hypotheses that regional and global total sodium concentrations: (i) are higher in patients than in controls and (ii) correlate with clinical presentation and neuropsychological function. Given the novelty of sodium imaging in traumatic brain injury, effect sizes from (i), and correlation types and strength from (ii), were compared to those obtained using standard diffusion imaging metrics. Twenty-seven patients (20 female, age 35.9 ± 12.2 years) within 2 months after injury and 19 controls were scanned with proton and sodium MRI at 3 Tesla. Total sodium concentration, fractional anisotropy and apparent diffusion coefficient were obtained with voxel averaging across 12 grey and white matter regions. Linear regression was used to obtain global grey and white matter total sodium concentrations. Patient outcome was assessed with global functioning, symptom profiles and neuropsychological function assessments. In the regional analysis, there were no statistically significant differences between patients and controls in apparent diffusion coefficient, while differences in sodium concentration and fractional anisotropy were found only in single regions. However, for each of the 12 regions, sodium concentration effect sizes were uni-directional, due to lower mean sodium concentration in patients compared to controls. Consequently, linear regression analysis found statistically significant lower global grey and white matter sodium concentrations in patients compared to controls. The strongest correlation with outcome was between global grey matter sodium concentration and the composite z-score from the neuropsychological testing. In conclusion, both sodium concentration and diffusion showed poor utility in differentiating patients from controls, and weak correlations with clinical presentation, when using a region-based approach. In contrast, sodium linear regression, capitalizing on partial volume correction and high sensitivity to global changes, revealed high effect sizes and associations with patient outcome. This suggests that well-recognized sodium imbalances in traumatic brain injury are (i) detectable non-invasively; (ii) non-focal; (iii) occur even when the antecedent injury is clinically mild. Finally, in contrast to our principle hypothesis, patients' sodium concentrations were lower than controls, indicating that the biological effect of traumatic brain injury on the sodium homeostasis may differ from that in other neurological disorders. Note: This figure has been annotated.

Introduction: Quantifying upper extremity (UE) motor impairment after stroke is impractical, limiting our ability to tailor rehabilitation training in real time. The current gold-standard measure of impairment, the Fugl-Meyer Assessment (FMA), is time-consuming and requires a trained assessor. The FMA furthermore does not assess functional motions in real-world contexts, which is exactly where we aim our rehabilitation interventions. Here, we took initial steps to develop an approach to automatically quantify UE motor impairment during functional task performance.
Method(s): We studied 51 chronic stroke patients (28F:23M; 57.7 (21.3-84.3) years old; 28L:23R paretic; FMA 43.1 (8-65)).We recorded upper body motion with 9 inertial measurement units (IMUs) while patients performed the FMA and a functional task (moving an object on a horizontal 8-target array). We trained a long short-term memory (LSTM) deep learning model to estimate FMA scores from the recorded motion (training set n=40; test set n=11; 4 LSTM layers with between-layer batch normalization; IMU data windows of 4s with slide of 1s). LSTM-generated impairment scores were computed from FMA motions or from functional motions. To ascertain the accuracy of the approach, we calculated the root mean square error (RMSE) and the Spearman correlation coefficient (rho) between the LSTM scores and the FMA scores from a trained expert. We also examined whether the performance of particular classes of functional primitives (i.e. reach, transport, or reposition) would be sufficient to accurately estimate impairment.
Result(s): Using motions from the FMA performance, our approach estimated FMA scores within 1.1 points of a trained assessor. Using motions from the functional task performance, our approach estimated FMA scores within 1.6 points. Correlation values between the FMA scores and LSTM scores were rho = 0.98 for FMA motions and rho = 0.96 for functional motions. Among the three functional primitives, reaches were the most informative for estimating the impairment scores (RMSE: 1.9 points), followed by transports (RMSE: 2.1 points), and repositions (RMSE: 2.8 points).
Discussion(s): We present a new approach that uses sensor-based motion capture and deep learning to automatically estimate UE motor impairment. This approach has high accuracy and shows high concurrent validity with the FMA, even when it assesses unrelated functional motions. Thus, it may be possible to directly measure impairment from performance of real-world functional tasks, which the FMA does not offer. Estimating impairment during stroke rehabilitation would enable clinicians to tailor treatment strategy in real time.

Background/Objectives/UNASSIGNED:Little is known regarding the prevalence and predictors of prolonged cognitive and psychological symptoms of COVID-19 among community-dwellers. We aimed to quantitatively measure self-reported metrics of fatigue, cognitive dysfunction, anxiety, depression, and sleep and identify factors associated with these metrics among United States residents with or without COVID-19. Methods/UNASSIGNED:We solicited 1000 adult United States residents for an online survey conducted February 3-5, 2021 utilizing a commercial crowdsourcing community research platform. The platform curates eligible participants to approximate United States demographics by age, sex, and race proportions. COVID-19 was diagnosed by laboratory testing and/or by exposure to a known positive contact with subsequent typical symptoms. Prolonged COVID-19 was self-reported and coded for those with symptoms ≥ 1 month following initial diagnosis. The primary outcomes were NIH PROMIS/Neuro-QoL short-form T-scores for fatigue, cognitive dysfunction, anxiety, depression, and sleep compared among those with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. Multivariable backwards step-wise logistic regression models were constructed to predict abnormal Neuro-QoL metrics. Results/UNASSIGNED:= 0.047), but there were no significant differences in quantitative measures of anxiety, depression, fatigue, or sleep. Conclusion/UNASSIGNED:Prolonged symptoms occurred in 25% of COVID-19 positive participants, and NeuroQoL cognitive dysfunction scores were significantly worse among COVID-19 positive subjects, even after accounting for demographic and stressor covariates. Fatigue, anxiety, depression, and sleep scores did not differ between COVID-19 positive and negative respondents.

Stereo-EEG (sEEG) is an invasive recording technique used to localize the seizure-onset zone for epilepsy surgery in people with drug-resistant focal seizures. Pathological crying reflects disordered emotional expression and the anterior insula is known to play a role in empathy and socio-emotional processing. We describe a patient where electrical stimulation mapping (ESM) of the anterior insula during sEEG generated pathological crying and profound sadness that was time-locked to the electrical stimulus. We evaluated a 35-year-old left-handed female for repeat epilepsy surgery. The patient had drug resistant focal impaired awareness seizures despite a previous left temporal neocortical resection informed by an invasive study using subdural grid and strip electrodes seven years earlier. She was studied invasively with 10 sEEG electrodes sampling temporal, occipital, and insular targets. In the process of functional mapping, stimulation of the anterior insular cortex provoked tearful crying with sad affect, reproducible upon repeat stimulation. Our case is unique in demonstrating transitory pathological crying with profound sadness provoked by ESM of the left anterior insula. Furthermore we demonstrate repeated time-synched crying from electrical stimulation, which supports the hypothesis that the anterior insula in the brain plays an important role in the biology of emotion, as implicated by previous studies.

The human brain functions at the center of a network of systems aimed at providing a structural and immunological layer of protection. The cerebrospinal fluid (CSF) maintains a physiological homeostasis that is of paramount importance to proper neurological activity. CSF is largely produced in the choroid plexus where it is continuous with the brain extracellular fluid and circulates through the ventricles. CSF movement through the central nervous system has been extensively explored. Across numerous animal species, the involvement of various drainage pathways in CSF, including arachnoid granulations, cranial nerves, perivascular pathways, and meningeal lymphatics, has been studied. Among these, there is a proposed CSF clearance route spanning the olfactory nerve and exiting the brain at the cribriform plate and entering lymphatics. While this pathway has been demonstrated in multiple animal species, evidence of a similar CSF egress mechanism involving the nasal cavity in humans remains poorly consolidated. This review will synthesize contemporary evidence surrounding CSF clearance at the nose-brain interface, examining across species this anatomical pathway, and its possible significance to human neurodegenerative disease. Our discussion of a bidirectional nasal pathway includes examination of the immune surveillance in the olfactory region protecting the brain. Overall, we expect that an expanded discussion of the brain-nose pathway and interactions with the environment will contribute to an improved understanding of neurodegenerative and infectious diseases, and potentially to novel prevention and treatment considerations.

We reviewed data on the American diet from 1800 to 2019. Methods: We examined food availability and estimated consumption data from 1800 to 2019 using historical sources from the federal government and additional public data sources. Results: Processed and ultra-processed foods increased from <5 to >60% of foods. Large increases occurred for sugar, white and whole wheat flour, rice, poultry, eggs, vegetable oils, dairy products, and fresh vegetables. Saturated fats from animal sources declined while polyunsaturated fats from vegetable oils rose. Non-communicable diseases (NCDs) rose over the twentieth century in parallel with increased consumption of processed foods, including sugar, refined flour and rice, and vegetable oils. Saturated fats from animal sources were inversely correlated with the prevalence of NCDs. Conclusions: As observed from the food availability data, processed and ultra-processed foods dramatically increased over the past two centuries, especially sugar, white flour, white rice, vegetable oils, and ready-to-eat meals. These changes paralleled the rising incidence of NCDs, while animal fat consumption was inversely correlated.

Introduction: With the corticospinal tract (CST), the corticoreticulospinal tract (CReST) is a major descending motor pathway with widespread bilateral innervation. In animals, CST damage causes a loss of motor control and prompts reorganization in the CReST, possibly with stronger connectivity to arm flexors (e.g. biceps (BIC)) than finger abductors (e.g. first dorsal interosseous (FDI)). CReST reorganization may also contribute to widespread muscle co-activations (i.e. abnormal synergy expression) in the paretic upper extremity (UE). Here, we posited that CReST reorganization after stroke targets the BIC more than the FDI in humans. We predicted that CReST activity, manifesting as abnormal synergy expression, would be more strongly evoked by skilled arm flexion than finger abduction in stroke patients.
Method(s): We studied the paretic UE of 14 chronic stroke patients (F: 8; mean age: 64 (44-85) years; mean post-stroke time: 5 (0.5-14.4) years) and the matched UE of 14 healthy controls (F: 6; mean age: 55 (36-81) years). Subjects used their arm or index finger to move an onscreen cursor through an arc-shaped channel while the remainder of the UE was restrained.We recorded effector kinematics with an infrared camera and electromyographic (EMG) signals from triceps (TRI), deltoid (DLT), BIC, extensor digitorum, flexor carpi radialis (FCR), flexor digitorum superficialis (FDS), and FDI. To quantify movement error, we calculated the average radial distance between the cursor path and the outer channel edge. To quantify abnormal muscle synergies, we applied a non-negative matrix factorization algorithm to the EMG data to identify muscle synergies and calculated the similarity of the synergy vectors between patients and controls; higher similarity scores indicate more normal synergy patterns. We calculated muscle co-activations using correlations between EMG signals of each muscle-pair. We examined group differences with independent t-tests and control-synergy relationships with correlations.
Result(s): Movement errors were higher in patients than controls for the arm (p<0.01) and trended higher for the finger (p=0.074). In the arm, movement errors were inversely related to synergy similarity scores (p<0.01). Higher errors also related to greater FDI-FCR, BIC-TRI, BIC-DLT, and TRI-DLT coactivation (all p<0.05). In the finger, movement errors were unrelated to synergy similarity scores. Lower movement errors related to greater FDSTRI co-activation (p<0.05).
Discussion(s): In the arm, we found that as motor control worsened, the expression of abnormal synergies increased, indicating that CReST activation may increase with loss of CST function. Muscle co-activation was widespread in the UE, in keeping with CReST's multilevel spinal branching. We did not find a relationship between motor control and synergy expression with finger movement, although the long-range co-contraction between the FDS and TRI may speak to a CST-driven stabilizing strategy. Our findings strengthen the notion that CReST reorganization after stroke may preferentially target the arm flexor and its synergies.

Several COVID-19 vaccines have recently been approved for emergency use according to governmental immunization programs. The arrival of these vaccines has created hope for people with Parkinson's disease (PD), as this can help to mitigate their risk of becoming infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to serious, life-threatening disease, at least among those with more advanced PD. However, both persons with PD and physicians looking after these individuals have expressed concerns about the vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment. Here, we discuss our perspective on these concerns, based on our interpretation of the literature plus the unfolding experience with widespread vaccination in the population at large. Because the benefits and risks of COVID-19 vaccines do not appear to be different than in the general population, we recommend COVID-19 vaccination with approved vaccines to persons with PD, unless there is a specific contraindication. Some caution seems warranted in very frail and terminally ill elderly persons with PD living in long-term care facilities.

BACKGROUND:Depressive symptoms predict increased risk for dementia decades before the emergence of cognitive symptoms. Studies in older adults provide preliminary evidence for an association between depressive symptoms and amyloid-β (Aβ) and tau accumulation. It is unknown if similar alterations are observed in midlife when preventive strategies may be most effective. OBJECTIVE:The study aim was to evaluate the association between depressive symptoms and cerebral Aβ and tau in a predominately middle-aged cohort with examination of the apolipoprotein (APOE) ɛ4 allele as a moderator. METHODS:Participants included 201 adults (mean age 53±8 years) who underwent 11C-Pittsburgh Compound B amyloid and 18F-Flortaucipir tau positron emission tomography (PET) imaging. Depressive symptoms were evaluated with the Center for Epidemiological Studies Depression Scale (CES-D) at the time of PET imaging, as well as eight years prior. Associations between depressive symptoms at both timepoints, as well as depression (CES-D≥16), with regional Aβ and tau PET retention were evaluated with linear regression adjusting for age and sex. Interactions with the APOE ɛ4 allele were explored. RESULTS:Depressive symptoms and depression were not associated with PET outcomes in the overall sample. However, among APOE ɛ4 allele carriers, there was a significant cross-sectional association between depressive symptoms and increased tau PET uptake in the entorhinal cortex (β= 0.446, SE = 0.155, p = 0.006) and amygdala (β= 0.350, SE = 0.133, p = 0.012). CONCLUSION:Although longitudinal studies are necessary, the results suggest that APOE ɛ4 carriers with depressive symptoms may present with higher susceptibility to early tau accumulation in regions integral to affective regulation and memory consolidation.